A New Destination for Oncology Education
September 15, 2025 | PIONEER, medical education, precision oncology
Medscape Oncology is pleased to announce the launch of a groundbreaking new learning space designed to provide education across tumor types and oncology disciplines: PIONEER – PrecIsion Oncology: Navigating EvidEnce for Real-world impact. This dedicated platform offers comprehensive, structured CME, organizing content by therapeutic target and tumor type to reflect the latest clinical and therapeutic advances. The result is a sharper focus on the science driving treatment decisions, ensuring physicians have the tools to deliver truly personalized care.
“This new learning center is all about providing clinicians with a one-stop destination for structured, consolidated CME, and helping them stay at the forefront of precision oncology to connect more patients with life-changing care. This is a vital resource for clinicians across oncology, and one we’re very proud to provide.” said Zhizhi Fiske, PhD, Director of Clinical Strategy at Medscape Education.
Surveys of Medscape physicians have found that 97% of physicians use biomarker or molecular target information when making treatment decisions. However, 85% of physicians frequently or occasionally encounter challenges in identifying appropriate therapies for patients with actionable mutations. Furthermore, 90% of physicians agree that a cross-tumor, target-based educational program would enhance their clinical decision-making.
“We surveyed over 100 physicians in the U.S. and E.U. The message was clear: doctors are eager to use biomarkers to guide treatment but struggle to keep up with rapid developments. Our findings confirm that while most find existing CME helpful, there is strong demand for interactive biomarker modules, expert panel discussions, and cross-tumor, target-based programs. A recurring theme was the desire for all these resources in one easily accessible place.” said Nabil Dorkhom, MD, Director Clinical Strategy at Medscape Education.
PIONEER is led by a distinguished steering committee of physician experts, including committee chair Fabrice André, MD, PhD, Head of Research, Professor of Oncology, Gustave Roussy, Villejuif, France; Benedikt Westphalen, MD, PhD, Chair, Center for Personalised Medicine,University Hospital, University of Munich, Munich, Germany; Vivek Subbiah, MD, Chief, Early-Phase Drug Development Sarah Cannon Research Institute,Nashville, Tennessee, United States; and Mary Beth Beasley, MD, Professor of Pathology, Head, Thoracic Pathology, Icahn School of Medicine at Mt. Sinai Medical Center, New York, United States.
“Precision oncology is revolutionizing cancer treatment, shifting from broad-spectrum therapies to precisely targeted interventions based on each patient’s unique molecular profile. For healthcare professionals, effective education and readily accessible, centralized information are paramount. This empowers them to harness cutting-edge diagnostics and apply optimized, individualized therapeutic strategies, ultimately improving patient outcomes,” commented committee chair Dr Fabrice André.
Physicians can start learning on the PIONEER microsite here.
Follow us on LinkedIn to stay up to date with the latest news and perspectives
About Medscape Education
Medscape Education is the leading online platform for continuing medical education (CME) and continuing education (CE), trusted by millions of healthcare professionals worldwide. With more than 30 speciality-specific learning destinations, it offers thousands of free, accredited courses for physicians, nurses, pharmacists, and other healthcare professionals. Medscape Education delivers high-impact, evidence-based education designed to support clinical decision-making, improve patient outcomes, and keep healthcare professionals current in a rapidly evolving medical landscape.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Pulse of AI Innovation: From More Data to Better Care
At the European Society of Cardiology (ESC) Congress, two of cardiology’s most influential voices sat down to talk about artificial intelligence at Medscape’s ‘The Pulse of AI Innovation’ event: Professor…
Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make decisions when real patient outcomes…
Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”
When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud to sponsor The John Ritter…
From Booth to Bavaria: A Recap of Impact at ESC 2026
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have already shown: when independent, evidence-based…
Why Modern Dermatology Demands Curiosity Over Precision
In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as Dr. Hawa Dumbuya, Director of…
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European Society of Cardiology Congress (ESC…
More Than Pink Walls: What Women-Centric Care Actually Requires
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the latest episode of the Hear…
Women in Healthcare Leadership Have a Lot to Say. Medscape’s Hear From Her Wins an APEX Grand Award.
Medscape Education has been honoured with the prestigious APEX Grand Award for Publication Excellence at…
Moving Beyond the 10%: A New Era in Preterm Birth Prevention
For decades, the rate of spontaneous preterm birth in the United States has hovered stubbornly around 10%. Despite advancements in other areas of medicine, prematurity remains the second leading cause…
Medscape Education to Showcase the Impact of Neurology CME at EAN 2026
Medscape Education, the leading global provider of continuing medical education (CME), has announced its agenda for the upcoming 12th Congress of the European Academy of Neurology (EAN) 2026 in Geneva,…